---
provider: perplexity
model: sonar-pro
cached: false
start_time: '2025-11-15T18:18:29.512838'
end_time: '2025-11-15T18:18:42.551616'
duration_seconds: 13.04
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    reasoning_effort: low
    search_domain_filter: []
    return_citations: true
    temperature: 0.0
citation_count: 11
---

## Question

Research the UCK1 (UCK1) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.

## Output

# UCK1 Gene: Molecular Function, Biological Processes, and Clinical Significance

## Molecular Function and Enzymatic Activity

UCK1 (Uridine-Cytidine Kinase 1) encodes a **uridine-cytidine kinase** that catalyzes the phosphorylation of uridine and cytidine nucleosides to their monophosphate formsâ€”uridine monophosphate (UMP) and cytidine monophosphate (CMP), respectively[1][6]. This enzyme is classified as a **kinase and transferase** based on its molecular function[9].

A critical characteristic of UCK1 is its **substrate specificity**. The enzyme does not phosphorylate deoxyribonucleosides or purine ribonucleosides, demonstrating selective recognition of pyrimidine ribonucleosides[1][11]. Additionally, UCK1 can utilize both **ATP and GTP as phosphate donors**, providing metabolic flexibility in nucleotide synthesis[1][6].

Beyond natural substrates, UCK1 demonstrates remarkable versatility in phosphorylating various **nucleoside analogs**, including 6-azauridine, 5-fluorouridine, 4-thiouridine, 5-bromouridine, N(4)-acetylcytidine, N(4)-benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5-methylcytidine, and N(4)-anisoylcytidine[1]. This capacity is particularly significant for pharmaceutical applications, as many anticancer and antiviral drugs are nucleoside analogs that require UCK1-mediated activation.

## Biological Processes and Metabolic Role

UCK1 functions as a **key enzyme in the nucleotide salvage pathway**, which recycles nucleosides back into nucleotide pools for DNA and RNA synthesis[3]. The nucleotide salvage pathway represents an energy-efficient alternative to de novo nucleotide synthesis, allowing cells to reuse existing nucleoside building blocks.

Human uridine-cytidine kinases, including UCK1 and its paralog UCK2, display **distinct functions in cellular metabolism**[3]. While both enzymes catalyze similar phosphorylation reactions, they exhibit different tissue distributions and regulatory properties, suggesting specialized roles in different cellular contexts.

## Genetic Organization and Structural Features

UCK1 is located on **chromosome 9** (positions 131,523,786-131,531,280 on the reverse strand)[10]. The gene exhibits significant structural complexity, encoding a **~30 kDa protein** and generating **15 different transcripts through alternative splicing**, which produce distinct protein isoforms[1][10]. This alternative splicing mechanism allows for functional diversity and tissue-specific expression patterns.

The gene has **202 orthologues** across different species and **3 paralogues** within the human genome, with UCK2 being identified as an important paralog[1][10]. This evolutionary conservation underscores the fundamental importance of pyrimidine nucleoside phosphorylation in cellular metabolism.

## Disease Associations

UCK1 has been associated with several pathological conditions[1]:

- **Lung Oat Cell Carcinoma**: Dysregulation of nucleotide metabolism through altered UCK1 expression may contribute to small cell lung cancer development
- **Muscular Dystrophy, Congenital, 1B**: Mutations or altered expression of UCK1 have been linked to this congenital muscular dystrophy form

Additionally, UCK1 expression levels correlate with sensitivity to certain anticancer agents. For example, sensitivity of human cancer cells to the anticancer ribonucleoside TAS-106 is correlated with UCK1 and UCK2 expression levels, as these enzymes are required for drug activation[4].

## Clinical and Pharmaceutical Implications

The ability of UCK1 to phosphorylate nucleoside analogs makes it a critical determinant of **drug efficacy and resistance** in cancer chemotherapy and antiviral therapy. Tumors with reduced UCK1 expression may develop resistance to nucleoside-based therapeutics, while high expression correlates with increased drug sensitivity. This relationship has important implications for personalized medicine approaches in cancer treatment and for understanding variable responses to antiviral medications.

## Citations

1. https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCK1
2. https://geneglobe.qiagen.com/us/knowledge/gene/ENSG00000198276
3. https://maayanlab.cloud/Harmonizome/gene/UCK1
4. https://www.wikigenes.org/e/gene/e/83549.html
5. https://www.sigmaaldrich.com/US/en/genes/uck1
6. https://www.ncbi.nlm.nih.gov/gene/83549
7. http://biogps.org/gene/83549/
8. https://platform.opentargets.org/target/ENSG00000130717
9. https://www.proteinatlas.org/ENSG00000130717-UCK1
10. http://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130717
11. https://www.uniprot.org/uniprotkb/Q9HA47/entry